Moreover, recent clinical studies have shown a correlation between high CD36 expression and a poor prognosis in several cancers, including esophageal squamous cell carcinoma, gastric cancer, lung squamous cell carcinoma, bladder cancer, luminal A breast cancer, glioblastoma, and acute myeloid leukemia [5,6,7,8,21,23]. Here, CD36 is linked to breast carcinoma.